Health
Genome Mapping Finds Hidden Mutations in 20% of Leukemia Cases
Optical genome mapping detects previously missed genetic variants in nearly 20% of acute leukemia patients, potentially changing treatment plans.
Key Takeaways
- OGM detects additional clinically significant mutations missed by standard testing in ~20% of cases
- Some newly found variants change patient risk classification and treatment recommendations
- Single assay replaces multiple conventional tests including karyotyping, FISH, and microarray
DE
DT Editorial AI··via medicalxpress.com